Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Finding Help After Nearly Losing Hope
A Chest of Charity
Many pharmaceutical companies provide assistance for medications that patients desperately need.
Lending a Hand
Adolescents and young adults need not face cancer’s financial burden alone.
Charitable organizations offer help to patients who are struggling.
Patients May Pay the Price for Cutting Cancer Costs
Overall, about a fourth of people have taken measures to decrease the cost of their or their loved one’s treatment — even if that means a negative impact on its effectiveness.
Weighing Costs and Consequences of Cancer Care Settings
A recent study found that the cost to patients with breast, lung and colorectal cancers treated in the hospital outpatient setting was nearly $8,000 more than those treated in the community setting.
Tips for Staying Sane While Dealing With Insurance
People with cancer have to gear up for the emotional and mental workout of dealing with insurance. Here are some tips for coping.
Understanding Cancer's Financial Landscape
Ashley Johnson, patient wellness navigator at Charleston Hematology and Oncology Associates, discusses how important it is for the whole health care team to better understand insurance and how patients pay for their cancer treatment.
New CAR T-Cell Therapy Comes With a Hefty Price Tag
The newly approved CAR T-cell therapy, Kymriah (tisagenlecleucel), is being put on the market with a price tag of $475,000 for a single infusion, which is within the range that oncologists predicted.
Money Is a Major Stressor for Patients With Cancer
Even cancer patients with insurance face difficulties with financial toxicity.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
What is your status?
Out of Treatment